Innovation Pharmaceuticals Inc (IPIX)

[daydreaming2]

Is this old news?

"Brilacidin-Otic is a novel topical anti-infective drug to treat ear infections. Often children with a history of frequent ear infections (otitis media) will have tubes placed in their tympanic membranes, which allows drainage into the external ear canal. In addition, children may develop an infection confined to the external ear canal. In either case, Brilacidin Otic could be helpful. Brilacidin-Otic topical drops can be applied directly to the infection, targeting difficult-to-treat bacteria such as Staph aureus, including methicillin-resistant Staph aureus (MRSA).

Brilacidin-Ocular: The company has identified ocular infections, such as keratitis, as an area of unmet medical need and significant commercial potential. Many topical ophthalmic anti-infective drugs that are used today for keratitis and conjunctivitis have serious limitations due to bacterial resistance and serious side effects. The Company has selected Dr. Reddy’s Laboratories Ltd. for the formulation of this drug.

The Company has selected Dr. Reddy’s Laboratories Ltd. for otic formulation of this drug."